Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
- 主要终点
- Changes in HbA1c
研究概览
简要总结
Therapeutic education is central to the management of diabetes, especially in children and adolescents. Camps represent an ideal environment for education. During camps, the campers receive both theoretical and practical information intended to improve their understanding and self-management of diabetes. The metabolic impact of diabetes camp is little known among children and adolescents living with type 1 diabetes in sub-Saharan Africa. The aimed of this study was to assess the changes in glycemic control and insulin doses in a group of children and adolescents living with type 1 diabetes in Cameroon during and after camp.
详细描述
Participants and setting:
In this study, the investigators analyzed the data of children and adolescents living with type 1 diabetes in Cameroon who attended the diabetes camp organized in Yaoundé in July 2013 and who came back for follow up at the CDiC clinic of the Yaoundé Central Hospital, 3 and 12 months later.
The "Changing Diabetes in Children" (CDiC) project offers logistics and free medical care to children living with type 1 diabetes in Cameroon, which includes free medical consultations, insulin, syringes, a glucose meter (Accu Check Active®, Roche Diagnostics GmbH, Mannheim, Germany) glucose strips, HbA1c monitoring every 3 months, collective therapeutic education sessions every 3 months and a yearly screening for complications. All children enrolled in the project have a systematic visit every three months. During this visit, clinical and biological assessment are done, also adjustment of treatment, therapeutic education and record of data in the medical record. Many children also consult outside systematic visits to collect the material for treatment or in case of an emergency related or not with diabetes. The forms of insulin available in the project are regular insulin (Actrapid®), intermediate-acting insulin (Insulatard®) and pre-mixed insulin (Mixtard 30®). HbA1c is assessed by the in2it™ point-of-care system (Bio-Rad Laboratories, Deeside, UK).
The CDiC program organizes a 5-day camp for about 50 children twice yearly. Participants are selected by the health care personnel who follow them, based on the availability of places and on the proximity to their homes. Children of less than 6 years old, those with an acute disease and those with incomplete recovery from a previous illness are not allowed to camp.
Camp organization:
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 23 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children living with type 1 diabetes and enrolled in the "Changing Diabetes in Children project".
- •Regular follow-up at the Yaoundé Central Hospital.
- •Aged between 6 and 23 years old.
- •Informed consent signed by parents or guardians prior to enrollment in the CDiC project allowing investigators of the project to used data for research.
- •Informed consent forms signed by parents or guardians before participation to the 2013 camp in Yaoundé.
排除标准
- •Nonattendance of the routinely follow-up visits at the CDiC clinic Yaoundé both at 3 and 12 months after camp.
研究组 & 干预措施
Insulin therapy and diabetes education
Children and adolescents living with type 1 diabetes already on insulin therapy received collective diabetes education during a five days camp.
干预措施: Insulin (Drug)
结局指标
主要结局
Changes in HbA1c
时间窗: Baseline to 3 months and 12 months after camp
Comparing the mean HbA1c of campers from baseline to 3 months and 12 months after camp
次要结局
- Changes in insulin doses(From the first day to the third day of camp, 3 months and 12 months after camp)
- Hypoglycemic episode per camper per day(From the first day to the third day of camp)
- Changes in weight(Baseline to 3 months and 12 months after camp)
研究者
Mesmin Dehayem Yefou
Consultant internist and endocrinologist, Yaounde Central Hospital
Yaounde Central Hospital